Drug Database
Back to search

Netherlands· NL-9ef71edb2ae5

MIBG (I123) 74 MBq/ml oplossing voor injectie

A iobenguane (123i) product containing jobenguaan i 123, registered in Netherlands by Curium Netherlands B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC V09IX01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMIBG (I123) 74 MBq/ml oplossing voor …ATCV09IX01REGISTER NO.NL-9ef71edb2ae5PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about jobenguaan i 123Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iobenguane (123i) is registered in 9 of 19 countries.

Countries holding a registration under ATC V09IX01 (iobenguane (123i)), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search iobenguane (123i) products by name

Iobenguane (123i) · ATC V09IX01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
JOBENGUAAN I 123
Manufacturer
Curium Netherlands B.V.
Country
Netherlands (NL)
ATC code
V09IX01
ATC class
Iobenguane (123I)
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    57736

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

241 interactions on record for iobenguane (123i).

Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iobenguane (123i) against other medicinesHow interaction checks work

Iobenguane (123i) · interactions on record

241 records

  • 143 severe
  • 98 moderate

Most severe, free to view

  • PhentermineA08AA01severe
  • FenfluramineA08AA02severe
  • DexfenfluramineA08AA04severe
  • MazindolA08AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iobenguane (123i) in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iobenguane (123i) products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Belgium · Adreview, Mibg (123i)
  • Czechia · Mibg (I123) Curium Netherlands
  • Germany · Adreview
  • Denmark · Adreview, Mibg (123i) Curium Netherlands
  • Spain · Adreview, Mibg (123i) Curium Pharma Spain
  • France · Adreview (123i), Mibg (123i) Curium Netherlands
  • United Kingdom (Northern Ireland) · Adreview, Mibg (123i) Curium Netherlands
  • Hungary · [123i]-Mibg, [123i]-Mibg Curium Netherlands
  • Ireland · Mibg (123i) Curium Netherlands
  • Italy · [123i]-Mibg, Adreview
  • Luxembourg · Adreview
  • Norway · Adreview
  • Slovakia · 123i Mibg Inj

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bfcf4d3d-48a3-43e5-be84-2f5a0b7a14fb
GET /v1/drugs/bfcf4d3d-48a3-43e5-be84-2f5a0b7a14fb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h57736_smpc.pdf",
  "strength": null,
  "atc_label": "Iobenguane (123 I)",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg57736",
  "excipients": [
    "CITROENZUUR 1-WATER (E 330)",
    "GENTISINEZUUR",
    "IOBENGUANE SULPHATE (RI)",
    "KOPERSULFAAT 5-WATER",
    "STANNOUS SULPHATE (RI)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "JOBENGUAAN I 123"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h57736.pdf",
  "authorised_at": "1995/06/15",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "57736",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about iobenguane (123i).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console